No abstract available
MeSH terms
-
Anticholesteremic Agents / therapeutic use*
-
Antineoplastic Agents / analysis
-
Apolipoproteins / blood
-
Apolipoproteins / drug effects
-
Biomarkers / blood
-
C-Reactive Protein / analysis
-
C-Reactive Protein / drug effects
-
Coronary Disease / blood
-
Coronary Disease / diet therapy*
-
Coronary Disease / drug therapy*
-
Female
-
Fibrinogen / analysis
-
Fibrinogen / drug effects
-
Hemostatics / analysis
-
Humans
-
Hyperlipidemias / blood
-
Hyperlipidemias / diet therapy
-
Hyperlipidemias / drug therapy
-
Lipoproteins / blood
-
Lipoproteins / drug effects
-
Male
-
Matrix Metalloproteinase 9 / blood
-
Matrix Metalloproteinase 9 / drug effects
-
Middle Aged
-
Placebo Effect
-
Protease Inhibitors / blood
-
Simvastatin / therapeutic use*
-
Thromboplastin / analysis
-
Thromboplastin / drug effects
-
Thrombosis / blood
-
Thrombosis / prevention & control*
-
Tissue Inhibitor of Metalloproteinase-1 / blood
-
Tissue Inhibitor of Metalloproteinase-1 / drug effects
-
Tumor Necrosis Factor-alpha / analysis
-
Tumor Necrosis Factor-alpha / drug effects
Substances
-
Anticholesteremic Agents
-
Antineoplastic Agents
-
Apolipoproteins
-
Biomarkers
-
Hemostatics
-
Lipoproteins
-
Protease Inhibitors
-
Tissue Inhibitor of Metalloproteinase-1
-
Tumor Necrosis Factor-alpha
-
lipoprotein-associated coagulation inhibitor
-
Fibrinogen
-
C-Reactive Protein
-
Thromboplastin
-
Simvastatin
-
Matrix Metalloproteinase 9